[1]
N. Azzman, M. S. A. Gill, S. S. Hassan, and N. Ahemad, “Exploring the potential of Designed Multiple Ligands (DML) strategy with quinolones as anticancer”, CTBP, vol. 17, no. 4A (Supplement), pp. 8–14, Dec. 2023.